The 95 percent plunge in the shares of Valeant Pharmaceuticals International Inc. since mid-2015 obviously was a disaster for investors...
Read More
This Bull Market Isn’t as Old as Some Seem to Think Lots of pundits and commentators use a flawed yardstick that doubles the age of...
Read More
We celebrate several market-related anniversaries this week. Perhaps the best known is the market low during the financial crisis, which...
Read More
Excessive CEO Pay for Dumb Luck The highest-paid managers tend to do the most to destroy shareholder value. Bloomberg, March 6, 2017...
Read More
How Expensive Are Stocks — Really? Investing isn’t easy. Trying to make it simpler won’t make it any easier. Bloomberg,...
Read More
How Expensive Are Stocks — Really? Investing isn’t easy. Trying to make it simpler won’t make it any easier. Bloomberg,...
Read More
Thou Shalt Not Buy Biblically Responsible ETFs Separate your politics from your portfolio. Bloomberg, March 2, 2017 ...
Read More
Something I try to stress in these columns is the importance of a valid process. Sure, I have a fondness for behavioral economics, but...
Read More
We all live in our own self-made bubbles. It is a never-ending effort to get outside that filter to find out what we might be missing....
Read More
The sorry state of American infrastructure is once again our focus. This time the peg is the Oroville Dam in California. It is the...
Read More
